会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • COMPOSITIONS FOR TREATING AND/OR PREVENTING DISEASES CHARACTERIZED BY THE PRESENCE OF METAL IONS
    • 用于治疗和/或预防由金属离子存在而引起的疾病的组合物
    • US20100184724A1
    • 2010-07-22
    • US12567678
    • 2009-09-25
    • Orrie FriedmanIvan CorreiaToby J. SommerDavid Alan Kew
    • Orrie FriedmanIvan CorreiaToby J. SommerDavid Alan Kew
    • A61K31/695A61P25/28
    • A61K31/695Y10S514/879
    • The present invention generally relates to the treatment and/or prevention of Alzheimer's disease, other neurodegenerative diseases, and/or diseases characterized by the presence of certain metal ions, by using certain compositions including organosilicon compounds. A composition of the invention may be administered to a mammal, such as a human. In some cases, the composition may include a silanol, a silandiol, a silantriol, or a cyclic organosilane, and/or be able to form a silanol, a silandiol, or a silantriol upon exposure to physiological conditions such as are found in the blood, in the stomach and/or gastrointestinal tract, or in the brain or other organ. In certain cases, the organosilicon compound may be bound to a moiety able to be transported across the blood-brain barrier into the brain, for example, an amino acid, a peptide, a protein, a virus, etc. The organosilicon compound may also be labeled (e.g., fluorescently or radioactively) in certain instances. In some embodiments, the composition, or a portion thereof, may sequester aluminum, copper, iron or other ions, for example, by electrostatically binding to the ions. The composition may also include other functionalities such as amines, certain alkyl and/or aryl moieties (including substituted alkyls and/or aryls), or hydrophobic moieties, for example, to facilitate transport of the organosilicon compound through the blood-brain barrier.
    • 本发明一般涉及通过使用包括有机硅化合物的某些组合来治疗和/或预防阿尔茨海默病,其他神经变性疾病和/或特征为某些金属离子的存在的疾病。 本发明的组合物可以施用于哺乳动物,例如人。 在一些情况下,组合物可以包括硅烷醇,硅烷醇,硅烷三醇或环状有机硅烷,和/或能够在暴露于例如在血液中发现的生理条件下形成硅烷醇,硅烷醇或硅烷醇 ,在胃和/或胃肠道,或在脑或其他器官中。 在某些情况下,有机硅化合物可以结合到能够通过血脑屏障转运到脑中的部分,例如氨基酸,肽,蛋白质,病毒等。有机硅化合物也可以 在某些情况下被标记(例如,荧光或放射性)。 在一些实施方案中,组合物或其一部分可以螯合铝,铜,铁或其它离子,例如通过静电结合离子。 组合物还可以包括其它官能团,例如胺,某些烷基和/或芳基部分(包括取代的烷基和/或芳基)或疏水部分,例如有助于有机硅化合物通过血脑屏障的转运。
    • 2. 发明授权
    • Compositions for treating and/or preventing diseases characterized by the presence of metal ions
    • 用于治疗和/或预防以金属离子存在为特征的疾病的组合物
    • US07595308B2
    • 2009-09-29
    • US11132170
    • 2005-05-17
    • Orrie FriedmanIvan CorreiaToby SommerDavid Alan Kew
    • Orrie FriedmanIvan CorreiaToby SommerDavid Alan Kew
    • A01N55/00
    • A61K31/695Y10S514/879
    • The present invention generally relates to the treatment and/or prevention of Alzheimer's disease, other neurodegenerative diseases, and/or diseases characterized by the presence of certain metal ions, by using certain compositions including organosilicon compounds. A composition of the invention may be administered to a mammal, such as a human. In some cases, the composition may include a silanol, a silandiol, a silantriol, or a cyclic organosilane, and/or be able to form a silanol, a silandiol, or a silantriol upon exposure to physiological conditions such as are found in the blood, in the stomach and/or gastrointestinal tract, or in the brain or other organ. In certain cases, the organosilicon compound may be bound to a moiety able to be transported across the blood-brain barrier into the brain, for example, an amino acid, a peptide, a protein, a virus, etc. The organosilicon compound may also be labeled (e.g., fluorescently or radioactively) in certain instances. In some embodiments, the composition, or a portion thereof, may sequester aluminum, copper, iron or other ions, for example, by electrostatically binding to the ions. The composition may also include other functionalities such as amines, certain alkyl and/or aryl moieties (including substituted alkyls and/or aryls), or hydrophobic moieties, for example, to facilitate transport of the organosilicon compound through the blood-brain barrier.
    • 本发明一般涉及通过使用包括有机硅化合物的某些组合来治疗和/或预防阿尔茨海默病,其他神经变性疾病和/或特征为某些金属离子的存在的疾病。 本发明的组合物可以施用于哺乳动物,例如人。 在一些情况下,组合物可以包括硅烷醇,硅烷醇,硅烷三醇或环状有机硅烷,和/或能够在暴露于例如在血液中发现的生理条件下形成硅烷醇,硅烷醇或硅烷醇 ,在胃和/或胃肠道,或在脑或其他器官中。 在某些情况下,有机硅化合物可以结合到能够通过血脑屏障转运到脑中的部分,例如氨基酸,肽,蛋白质,病毒等。有机硅化合物也可以 在某些情况下被标记(例如,荧光或放射性)。 在一些实施方案中,组合物或其一部分可以螯合铝,铜,铁或其它离子,例如通过静电结合离子。 组合物还可以包括其它官能团,例如胺,某些烷基和/或芳基部分(包括取代的烷基和/或芳基)或疏水部分,例如有助于有机硅化合物通过血脑屏障的转运。
    • 4. 发明授权
    • Compositions for treating and/or preventing diseases characterized by the presence of metal ions
    • 用于治疗和/或预防以金属离子存在为特征的疾病的组合物
    • US08273726B2
    • 2012-09-25
    • US12567678
    • 2009-09-25
    • Orrie FriedmanIvan CorreiaToby J. SommerDavid Alan Kew
    • Orrie FriedmanIvan CorreiaToby J. SommerDavid Alan Kew
    • A01N55/00A61K31/695
    • A61K31/695Y10S514/879
    • The present invention generally relates to the treatment and/or prevention of Alzheimer's disease, other neurodegenerative diseases, and/or diseases characterized by the presence of certain metal ions, by using certain compositions including organosilicon compounds. A composition of the invention may be administered to a mammal, such as a human. In some cases, the composition may include a silanol, a silandiol, a silantriol, or a cyclic organosilane, and/or be able to form a silanol, a silandiol, or a silantriol upon exposure to physiological conditions such as are found in the blood, in the stomach and/or gastrointestinal tract, or in the brain or other organ. In certain cases, the organosilicon compound may be bound to a moiety able to be transported across the blood-brain barrier into the brain, for example, an amino acid, a peptide, a protein, a virus, etc. The organosilicon compound may also be labeled (e.g., fluorescently or radioactively) in certain instances. In some embodiments, the composition, or a portion thereof, may sequester aluminum, copper, iron or other ions, for example, by electrostatically binding to the ions. The composition may also include other functionalities such as amines, certain alkyl and/or aryl moieties (including substituted alkyls and/or aryls), or hydrophobic moieties, for example, to facilitate transport of the organosilicon compound through the blood-brain barrier.
    • 本发明一般涉及通过使用包括有机硅化合物的某些组合来治疗和/或预防阿尔茨海默病,其他神经变性疾病和/或特征为某些金属离子的存在的疾病。 本发明的组合物可以施用于哺乳动物,例如人。 在一些情况下,组合物可以包括硅烷醇,硅烷醇,硅烷三醇或环状有机硅烷,和/或能够在暴露于例如在血液中发现的生理条件下形成硅烷醇,硅烷醇或硅烷醇 ,在胃和/或胃肠道,或在脑或其他器官中。 在某些情况下,有机硅化合物可以结合到能够通过血脑屏障转运到脑中的部分,例如氨基酸,肽,蛋白质,病毒等。有机硅化合物也可以 在某些情况下被标记(例如,荧光或放射性)。 在一些实施方案中,组合物或其一部分可以螯合铝,铜,铁或其它离子,例如通过静电结合离子。 组合物还可以包括其它官能团,例如胺,某些烷基和/或芳基部分(包括取代的烷基和/或芳基)或疏水部分,例如有助于有机硅化合物通过血脑屏障的转运。